Katie Devine, PhD, MPH
Associate Director, New Jersey Pediatric Hematology Oncology Research Center of Excellence (NJ PHORCE)
Associate Professor of Pediatrics
Vanessa Johnson
Administrative Research Associate
vj146@cinj.rutgers.edu
Rachel Wagner
rbw52@cinj.rutgers.edu
Kohler RE, Dharamdasani T, Tarn J, Macenat M, M Ferrante J, Mathur S, Bandera EV, Kinney AY, Satagopan JM. Breast cancer beliefs and screening behaviors among South Asian immigrant women living in the United States. BMC Womens Health. 2025 Mar 4;25(1):98.
Dr. Racquel “Kelly” Kohler received her MSPH in Health Policy and Management and her PhD in Health Services Research at the University of North Carolina at Chapel Hill. She lived and worked in Malawi as a Fogarty fellow to conduct her mixed methods dissertation study on advanced breast cancer diagnosis. Dr. Kohler completed her postdoctoral fellowship in Cancer Prevention at the Harvard T.H. Chan School of Public Health and Dana-Farber Cancer Institute.
The mission of Rutgers Cancer Institute, New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, is to conduct cutting-edge research and translate those findings into new and improved therapies.
Patricia Helmick (Meetings & Appointments)
609-633-0500
Patricia.Helmick@doh.nj.gov
Cindy York (Grants & Budgets)
Administrative Research Associate
cy291@cinj.rutgers.edu
Lisa Paddock, PhD, MPH
Deputy Director
Cancer Surveillance Research
Cancer Epidemiology Services
Lisa.Paddock@doh.nj.gov
The Section of Pediatric Population Science, Outcomes, and Disparities Research, within the Division of Pediatric Hematology/Oncology and the
Home | Research Accomplishments | Services & Requests | Equipment |
Researchers from Rutgers Cancer Institute, with RWJBarnabas Health and in collaboration with investigators from MD Anderson, discovered a novel triple immunotherapy combination, targeting checkpoints on both T cells and myeloid suppressor cells, that dramatically improved anti-tumor responses by reprogramming the tumor microenvironment in preclinical models of PDAC.
